ZACKS

搜索文档
Meta Platforms Rises 7% in a Month: Buy, Sell or Hold the Stock?
ZACKS· 2025-08-08 00:46
Key Takeaways META shares are benefiting from strong earnings and revenue growth, and positive outlook.New AI-powered ad tools lifted conversions and engagement across Instagram and Facebook.META expects Q3 revenues of $47.5B-$50.5B, aided by strong platform user growth.Meta Platforms (META) shares have climbed 7.2% in the past month. Since the second-quarter 2025 results, reported on July 30, META shares have surged 11%, reflecting strong revenues and earnings growth as well as positive guidance. Meta Plat ...
MKSI Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Rise
ZACKS· 2025-08-08 00:46
Key Takeaways MKSI posted Q2 earnings of $1.77 per share topping consensus estimates.Semiconductor revenues rose 17.1% Y/Y, driving overall 9.7% revenue growth.MKSI guides Q3 earnings at $1.80/share and revenues of $960M, plus or minus $40M.MKS Inc. (MKSI) reported second-quarter 2025 adjusted earnings of $1.77 per share, beating the Zacks Consensus Estimate by 9.94%. The figure increased 15.7% year over year.Revenues of $973 million beat the consensus mark by 4.61% and increased 9.7% year over year.MKSI sh ...
Lowe's (LOW) Could Be a Great Choice
ZACKS· 2025-08-08 00:46
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that ...
LLY Stock Sinks Despite Q2 Earnings Beat as Obesity Pill Disappoints
ZACKS· 2025-08-08 00:35
Key Takeaways LLY beat Q2 estimates with EPS of $6.31 and revenues of $15.56B, driven by Mounjaro and Zepbound sales.Mounjaro and Zepbound sales rose sharply, aided by global launches and ramped-up supply.Shares fell after orforglipron's 12.4% weight loss missed investor expectations in the obesity trial.Eli Lilly and Company (LLY) reported second-quarter 2025 adjusted earnings per share (“EPS”) of $6.31, which beat the Zacks Consensus Estimate of $5.61 per share. Earnings rose 61% year over year.Revenues o ...
Kennametal's Q4 Earnings Miss Estimates, Revenues Decline Y/Y
ZACKS· 2025-08-08 00:35
Key Takeaways KMT's Q4 adjusted EPS fell 30.6% to $0.34, missing estimates on weak sales and higher costs.Q4 revenues dropped 5% to $516M, with both Metal Cutting and Infrastructure segments declining.Gross margin shrank 300 bps to 28.2% as inflation and lower production volumes hit profitability.Kennametal Inc. (KMT) reported fourth-quarter fiscal 2025 (ended June 30, 2025) adjusted earnings of 34 cents per share, which missed the Zacks Consensus Estimate of 40 cents. The bottom line decreased 30.6% from t ...
Buy These 5 Stocks With Rising Cash Flows to Scoop Up Big Gains
ZACKS· 2025-08-08 00:31
Key Takeaways MARUY, MTRN, BWMX, ESEA and SHG all show rising cash flows vs. their 5-year average per-share cash flow.MARUY's earnings estimate for FY March 2026 rose 18.8% in the past week; it holds a VGM Score of A.BWMX's earnings estimate rose 11.3% in a month, backed by strength in home organization and smart furniture.In the final leg of the ongoing reporting cycle, it might seem appropriate to lay a wager on stocks based on profit numbers and earnings surprises. However, looking beyond profits and eva ...
Corpay Earnings Meet Estimates in Q2, Revenues Increase 13% Y/Y
ZACKS· 2025-08-08 00:31
Key Takeaways CPAY reported Q2 EPS of $5.13, up 12.8% y/y, meeting estimates. Revenue rose 13% to $1.1 billion.Corporate payments revenues jumped 36% y/y, while lodging payments fell 2% and missed estimates.The 2025 revenue outlook was raised to $4.41-$4.49B. The EPS view was lifted to $20.86-$21.26 for the year.Corpay, Inc.’s (CPAY) second-quarter 2025 earnings per share met the consensus mark, while revenues beat the same.CPAY’s earnings per share of $5.13 met the consensus estimate by a slight margin and ...
ETFs Set to Benefit from Apple's $100B U.S. Bet
ZACKS· 2025-08-08 00:31
Apple (AAPL) announced a major expansion of its U.S. investment strategy with an additional $100 billion injection into American manufacturing over the next four years. This would follow the iPhone maker’s previously pledged $500 billion commitment to U.S. operations, which included a Texas-based AI server plant developed in partnership with local suppliers.The announcement comes amid renewed pressure from Trump, who urged American tech companies to shift production back home. Trump has threatened to impose ...
Royal Gold Earnings Beat Estimates in Q2, Revenues Increase Y/Y
ZACKS· 2025-08-08 00:20
Key Takeaways RGLD reported Q2 adjusted EPS of $1.81, beating estimates and rising 45% y/y.Revenues hit a record $209M, driven by metal prices, and gold output at Penasquito and Manh Choh.Adjusted EBITDA rose 24.5% to $175M, with margins improving to 83.8% from 81% last year.Royal Gold, Inc. (RGLD) reported adjusted earnings per share (EPS) of $1.81 in second-quarter 2025, beating the Zacks Consensus Estimate of $1.70. The bottom line increased 45% year over year.Including one-time items, the company report ...
MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
ZACKS· 2025-08-08 00:20
Key Takeaways MIRM posted a Q2 loss of $0.12 per share, which beat estimates and narrowed from $0.52 a year ago.Q2 revenues rose 64.1% Y/Y to $127.8M, fueled by strong Livmarli and bile acid product sales.MIRM lifted 2025 revenue guidance to $490M-$510M, up from the previous $435M-$450M range.Mirum Pharmaceuticals (MIRM) reported a loss of 12 cents per share for the second quarter of 2025, much narrower than the Zacks Consensus Estimate of a loss of 31 cents. The company had incurred a loss of 52 cents per ...